Gerresheimer is a global partner for packaging and drug delivery systems, helping protect health and support quality of life. Its approximately 13,000 employees develop and produce solutions across 39 plants in Europe, the Americas and Asia, combining local customer knowledge with global capabilities. The company serves pharmaceutical, biotechnology, cosmetics, food and beverage markets, with products spanning glass and plastic packaging, medical devices and integrated drug delivery systems.

Its portfolio includes primary pharmaceutical packaging such as ampoules, syringes, cartridges, vials, closures and containers, as well as proprietary devices including autoinjectors, inhalers and pen injectors. Gerresheimer also offers product development, industrialization, contract manufacturing, project and quality management, and digital solutions for supply chains and drug delivery. For diagnostics and medical technology, its services include laboratory disposables, point-of-care tests, mold making, automation and small-batch production. Cosmetics customers can choose molded and tubular glass, plastic packaging, decoration and customized solutions. The company emphasizes quality, hygiene and safety, and aims to procure renewable electricity by 2030 while reducing CO2 emissions by 50% from its baseline.